Together, our data demonstrate that nucleolar FAK promotes ribosome biogenesis and protein synthesis to drive thyroid cancer growth and survival, and thus presents a promising therapeutic target to treat thyroid and other FAK-driven cancers. The gene discussed is PTK2; the disease is thyroid cancer.